The results of time-dependent ROC analysis curves showed that the AUC values for predicting the survival rate of HNSCC patients at 3, 7, and 10 years based on the expression level of CERCAM were above 0.55, as shown in Fig. 4b. The gene discussed is CERCAM; the disease is head and neck squamous cell carcinoma.